192 results

• Diagnostic Test Needed to Identify Drugs Causing Stevens-Johnson Syndrome: Study

  June 23, 2023

  Stephanie Yanovich

  A new study calls for more accurate testing for drugs which may be linked to Stevens-Johnson Syndrome skin reactions.

• Study Finds Media Coverage Can Increase Drug Prescribing Despite Lack of Scientific Evidence

  June 19, 2023

  Martha Garcia

  Harvard researchers warn that media coverage can convince consumers to seek drug prescriptions they do not need and which may have no benefits for them.

• Pentagon Asks Valisure, Not FDA, to Make Sure Drugs for Servicemembers are Safe

  June 13, 2023

  Irvin Jackson

  Bloomberg News reports that the Department of Defense is in talks with the independent drug testing lab Valisure to have it test generic drugs given to the military for safety and effectiveness.

• Diabetes Patients Face Worse Outcomes from Stevens-Johnson Syndrome: Study

  June 7, 2023

  Stephanie Yanovich

  The findings of a new study indicate those with diabetes face a higher risk of sepsis, death and other risks from Stevens-Johnson Syndrome.

• Preventable Hospital Errors Identified In Nearly 7% Of Admissions in New Study

  January 12, 2023

  Martha Garcia

  While nearly 25% of patients are likely to suffer adverse events in the hospital, many of those may be preventable, according to the findings of a new study.

• FDA Calls for Restrictions on Ovarian Cancer Drug Rubraca Due to High Mortality Rates

  November 18, 2022

  Irvin Jackson

  The FDA is seeking restrictions on the ovarian cancer drug Rubraca, following data indicating it may increase the risk of death in some patients.

• Study Highlights Link Between Tepezza and Hearing Problems After Four Injections of the Thyroid Eye Disease Drug

  November 7, 2022

  Irvin Jackson

  A new study finds that most Tepezza patients suffer some degree of hearing loss, and a third of those may not recover their hearing.

• Copiktra Side Effects Too Dangerous for Some Cancer Patients, FDA Advisory Committee Decides

  September 26, 2022

  Russell Maas

  An FDA advisory committee voted to recommend the agency not approve Copiktra for some blood cancer patients due to an increased risk of death.

• FDA Issues New Draft Guidance on Children’s Use in Clinical Trials

  September 26, 2022

  Martha Garcia

  The FDA has proposed new guidelines for safely including children in clinical trials.

• Cancer Drug Copiktra Could Shorten Life Expectancy in Some Patients, FDA Reviewers Warn

  September 23, 2022

  Irvin Jackson

  An advisory committee is being asked to review the benefits and risks of Copiktra, a blood cancer drug FDA experts say appears to lower life expectancy in some cancer patients.